The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneMicrobiota and the control of blood-tissue barriersNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapySerum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.Effects of CBV, CBF, and blood-brain barrier permeability on accuracy of PASL and VASO measurement.Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.The blood-brain barrier in health and disease.Pleiotropic effects of the HMG-CoA reductase inhibitorsHuman brain endothelial cells are responsive to adenosine receptor activation.Gastroenterology issues in schizophrenia: why the gut matters.Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoproteinInflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4.von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitisBrain-specific proteins decline in the cerebrospinal fluid of humans with Huntington diseaseThe importance of NAD in multiple sclerosisEvidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherin.Roles for lysophospholipid S1P receptors in multiple sclerosis.Neurovascular unit: a focus on pericytes.Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.TREK-king the blood-brain-barrier.Regulation of human glia by multiple sclerosis disease modifying therapies.Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection.Increased expressions of ADAMTS-13 and apoptosis contribute to neuropathology during Toxoplasma gondii encephalitis in mice.Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?Retinal and Cortical Blood Flow Dynamics Following Systemic Blood-Neural Barrier DisruptionEstimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA.CD4+CD25+CD127dimFoxp3+ T cells are cytotoxic for human neurons.Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells.An introduction to the microbiome and MS.Temporal and Spatial Effects of Blast Overpressure on Blood-Brain Barrier Permeability in Traumatic Brain Injury.Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.
P2860
Q21558407-1D5C40BF-BD63-4D49-BC7E-7370DAB3FDBEQ26785532-DB3DF7E9-A958-4797-A24C-45C4CDEAE113Q26999061-F025B02C-3F4A-4E69-BE99-04E109A4B56DQ27011473-A27F5F0C-F057-4586-8DA8-4EA16333AD8DQ33374004-1346E342-DD04-4FBE-B2C5-D604DD62C6D0Q33530483-F8087E49-AD38-4976-851D-7975E5916DD2Q34003724-5383134C-5B6C-4CEA-8821-EDEDD0E93C9FQ34320420-360736C7-B42F-4AF8-BE5C-42C09A004014Q34894749-4343D0FE-E041-4281-BC56-8F6657A54937Q35136806-903D3FB5-C7AA-4059-A64A-F0A5EB95715FQ35577667-80E337A8-5E1B-4058-8BD0-73A5DE2DB12CQ35623470-B2E73C41-9C8E-4CE7-A280-86403DDA07BAQ36059965-AE769AF5-9BE3-4FBD-9720-15D783D7B243Q36224032-456C8782-1033-4A15-BEF7-2534121A1C6AQ36853655-521218B8-6194-470C-9AE5-2350480FFC65Q37113861-297C688D-1992-4FAA-9464-F68CF2D081BAQ37118012-733F3A08-F87C-4710-9E7A-8FF6F298131EQ37630213-BD9E241C-7212-4A4D-9382-97E726DE0B5DQ37803419-AA69C321-5639-4D35-A559-9190D757B162Q37988811-420CB960-ED4E-4675-9907-EAE80A1174FDQ38020536-599D01EC-92E6-4F81-AF4A-1B29A9D137DFQ38190042-75BB62BC-E883-4BE7-98B6-7FB43404AE65Q38563863-72ED57E5-191D-466C-924F-EA7A08520FD5Q40759669-796FD8F4-092B-48DA-ACD5-FC9D55CC31F2Q40920543-273DB2CC-E79F-47D8-B6F7-BF05420B56D1Q41528091-E2BCAF0F-64F1-43B6-91BD-82E0C2546A83Q42694289-09DCEE99-3C5F-4ED9-9675-C17375C440DDQ42955082-EFAB3C08-D831-4978-BECE-6ED00AF0236CQ44491431-175E7FEE-78C8-4E0D-AB11-E75270093AA0Q47672573-111F747E-586B-452C-A1E5-8FF466115D89Q50146314-C6ED79B5-EFC1-4F1B-94AC-8DFEFBD460EAQ55261835-E10EE048-69FE-46D0-8981-9B089EAD6553Q55461485-1AC433D3-CE35-4F7A-96FF-46F1214F8D31
P2860
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@ast
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@en
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@nl
type
label
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@ast
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@en
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@nl
prefLabel
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@ast
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@en
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@nl
P2860
P921
P1433
P1476
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting
@en
P2093
Andrés Villa
P2860
P304
P356
10.1080/08916930601183522
P407
P577
2007-03-01T00:00:00Z